Advances in “Liquid Biopsy” and Circulating Tumor DNA
In this episode, Dr. Peter Dziegielewski explores the concept of liquid biopsy—an innovative approach to cancer diagnosis. Learn about its applications in tracking treatment efficacy, monitoring minimal residual disease, and the evolving role of circulating tumor DNA. This episode is essential for anyone interested in the future of oncology. Don’t forget to subscribe for more insights!
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.